We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AMCR:NYSEAmcor plc Analysis

Data as of 2026-09-05 - not real-time

$45.15

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Amcor plc is bullish at $45.15, with short-term averages leading the long-term ones. The last 30 days have gained 1.4%. RSI sits at 44.0, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $44.81 and resistance at $48.94.
Multiples put this in fair territory at a P/E of 19.0. Analyst price targets sit 10.6% above the current price. Revenue is growing at 25.9% on a 4.7% profit margin. The 5.67% dividend yield looks stretched against payout coverage.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 26.0%, a beta of 0.82 and a maximum drawdown of 27.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.

Top Market Events

Seeking Alpha1monAmcor: Dividend Appeal Is Not Enough To Offset Flat FCF And Margin CompressionAmcor plc is rated a...Hosted on MSN24dAmcor beats quarterly forecasts as investors weigh transition-period outlookAmcor plc NYSE:AMCR...Zurich, Switzerland-based Amcor plc AMCR engages in the production and sale of packaging products in North America and...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 42.75
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Dividend yield of 5.67% looks stretched against payout coverage
  • Trading above the 200-day average of 42.75

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Dividend yield of 5.67% looks stretched against payout coverage
  • Analyst targets imply +10.6% versus the current price
  • Revenue growth of +25.9%

Key Metrics & Analysis

Financial Health

Revenue Growth25.90%
Profit Margin4.71%
P/E Ratio19.0
ROE9.40%
ROA3.57%
Debt/Equity128.29
P/B Ratio1.8
Op. Cash Flow$2.2B
Free Cash Flow$1.5B

Technical Analysis

TrendBullish
RSI44.0
Support$44.81
Resistance$48.94
MA 20$46.68
MA 50$45.33
MA 200$42.75
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$81.91
Target Price$49.93
Upside/Downside10.60%
GradeFair
TypeBlend
Dividend Yield5.67%

Risk Assessment

Beta0.82
Volatility26.04%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.